Consolidated Statements of Changes in Equity - USD ($) |
Ordinary Shares
Class A
|
Ordinary Shares
Class B
|
Additional Paid-in Capital |
Statutory Reserve |
Accumulated Deficit |
Accumulated Other Comprehensive Loss Income (Loss) |
Non-controlling Interest |
Total |
|||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance at Dec. 31, 2021 | $ 1,946 | $ 550 | $ 22,986,975 | $ 1,199,054 | $ 7,180,891 | $ 1,197,006 | $ 32,566,422 | ||||
| Balance (in Shares) at Dec. 31, 2021 | [1] | 1,945,343 | 549,772 | ||||||||
| Issuance of Class A Ordinary Shares in connection with public offering | $ 106 | 1,850,638 | 1,850,744 | ||||||||
| Issuance of Class A Ordinary Shares in connection with public offering (in Shares) | 106,000 | [1] | |||||||||
| Share-based compensation expenses | $ 2 | 160,775 | 160,777 | ||||||||
| Share-based compensation expenses (in Shares) | 1,800 | [1] | |||||||||
| Acquisition of subsidiaries | 2,978,903 | 2,978,903 | |||||||||
| Net (loss) income | (2,940,891) | 118,572 | (2,822,319) | ||||||||
| Appropriation of statutory reserve | 115,963 | (115,963) | |||||||||
| Foreign currency translation adjustments | (1,708,830) | (6,432) | (1,715,262) | ||||||||
| Balance at Dec. 31, 2022 | $ 2,054 | $ 550 | 24,998,388 | 1,315,017 | 4,124,037 | (511,824) | 3,091,043 | 33,019,265 | |||
| Balance (in Shares) at Dec. 31, 2022 | [1] | 2,053,143 | 549,772 | ||||||||
| Share-based compensation expenses | $ 2 | 135,545 | 135,547 | ||||||||
| Share-based compensation expenses (in Shares) | 1,800 | [1] | |||||||||
| Net (loss) income | (11,335,911) | 28,672 | (11,307,239) | ||||||||
| Appropriation of statutory reserve | 56,151 | (56,151) | |||||||||
| Foreign currency translation adjustments | (721,077) | (88,326) | (809,403) | ||||||||
| Balance at Dec. 31, 2023 | $ 2,056 | $ 550 | 25,133,933 | 1,371,168 | (7,268,025) | (1,232,901) | 3,031,389 | 21,038,170 | |||
| Balance (in Shares) at Dec. 31, 2023 | [1] | 2,054,943 | 549,772 | ||||||||
| Sales of ordinary shares | $ 13,094 | 3,825,106 | 3,838,200 | ||||||||
| Sales of ordinary shares (in Shares) | 13,094,000 | [1] | |||||||||
| Exercise of warrants | $ 9,600 | (9,600) | |||||||||
| Exercise of warrants (in Shares) | 9,600,000 | [1] | |||||||||
| Share-based compensation expenses | $ 39 | 109,675 | 109,714 | ||||||||
| Share-based compensation expenses (in Shares) | 39,000 | [1] | |||||||||
| Issuance of fraction shares for share consolidation | $ 51 | (51) | |||||||||
| Issuance of fraction shares for share consolidation (in Shares) | 51,188 | [1] | |||||||||
| Net (loss) income | (643,229) | 369,816 | (273,413) | ||||||||
| Appropriation of statutory reserve | 161,208 | (161,208) | |||||||||
| Reversal of statutory reserve | (113,186) | 113,186 | |||||||||
| Foreign currency translation adjustments | (473,559) | (88,059) | (561,618) | ||||||||
| Balance at Dec. 31, 2024 | $ 24,840 | $ 550 | $ 29,059,063 | $ 1,419,190 | $ (7,959,276) | $ (1,706,460) | $ 3,313,146 | $ 24,151,053 | |||
| Balance (in Shares) at Dec. 31, 2024 | [1] | 24,839,131 | 549,772 | ||||||||
| |||||||||||
| X | ||||||||||
- Definition Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of shares issued which are neither cancelled nor held in the treasury. No definition available.
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Value of stock issued pursuant to acquisitions during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Value of stock issued as a result of the exercise of stock options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Represents amount of appropriation of statutory reserve. No definition available.
|
| X | ||||||||||
- Definition Issuance of fraction shares for share consolidation. No definition available.
|
| X | ||||||||||
- Definition Number of shares of stock issued attributable to transactions classified as Sale of ordinary shares. No definition available.
|
| X | ||||||||||
- Definition Stock issued during period, value issuance of fraction shares for share consolidation. No definition available.
|
| X | ||||||||||
- Definition Reversal of statutory reserve. No definition available.
|
| X | ||||||||||
- Definition Value of shares of stock issued attributable to transactions classified as sale of ordinary share. No definition available.
|